YIH
PBYI icon

Y-Intercept (HK)’s Puma Biotechnology PBYI Stock Holding History

Y-Intercept (HK)’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Buy
+26,222
New +$192K ﹤0.01% 1559
2024
Q2 		– Sell
-19,383
Closed -$103K – 1790
2024
Q1 		$103K Buy
19,383
+1,437
+8% +$7.74K 0.01% 1276
2023
Q4 		$77.7K Buy
+17,946
New +$59.5K 0.01% 1132

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Y-Intercept (HK)'s PBYI Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Puma Biotechnology (PBYI) in Q2 2026: 26,222 shares worth $213K. The stake represents ﹤0.01% of the portfolio and ranks #1559 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in PBYI as recently as Q1 2024.

Y-Intercept (HK) first reported a position in PBYI in Q4 2023 and has held it in 3 quarters since. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Y-Intercept (HK) held 26,222 shares of Puma Biotechnology worth $213K as of Q2 2026.
  • Puma Biotechnology was a new Y-Intercept (HK) position in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1559 holding.
  • Y-Intercept (HK) first reported a position in Puma Biotechnology in Q4 2023 and has held it in 3 quarters since.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.